Capstone Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,300
Closed -$207K 1889
2025
Q4
$207K Sell
2,300
-1,800
-44% -$171K ﹤0.01% 1493
2025
Q3
$404K Buy
+4,100
New +$406K ﹤0.01% 1513
2025
Q2
Sell
-5,900
Closed -$668K 1762
2025
Q1
$668K Sell
5,900
-2,000
-25% -$214K ﹤0.01% 1008
2024
Q4
$834K Buy
7,900
+2,500
+46% +$268K ﹤0.01% 1135
2024
Q3
$583K Sell
5,400
-900
-14% -$98.2K ﹤0.01% 1161
2024
Q2
$684K Buy
6,300
+2,100
+50% +$248K ﹤0.01% 1148
2024
Q1
$554K Sell
4,200
-2,300
-35% -$287K ﹤0.01% 1495
2023
Q4
$791K Buy
6,500
+6,200
+2,067% +$692K ﹤0.01% 1142
2023
Q3
$33.7K Sell
300
-500
-63% -$63.5K ﹤0.01% 2041
2023
Q2
$116K Hold
800
﹤0.01% 1675
2023
Q1
$103K Buy
+800
New +$100K ﹤0.01% 1365
2022
Q4
Sell
-9,700
Closed -$1.01M 1683
2022
Q3
$1.01M Buy
9,700
+100
+1% +$11K 0.01% 1002
2022
Q2
$1.01M Sell
9,600
-8,100
-46% -$961K ﹤0.01% 999
2022
Q1
$2.26M Sell
17,700
-4,857
-22% -$585K 0.01% 993
2021
Q4
$2.78M Buy
22,557
+7,313
+48% +$957K ﹤0.01% 1019
2021
Q3
$2.17M Sell
15,244
-1,236
-8% -$182K ﹤0.01% 1160
2021
Q2
$2.57M Buy
16,480
+5,356
+48% +$868K 0.01% 939
2021
Q1
$1.73M Buy
11,124
+7,004
+170% +$1.08M 0.01% 975
2020
Q4
$616K Buy
4,120
+3,811
+1,233% +$538K ﹤0.01% 1205
2020
Q3
$41K Buy
+309
New +$40.4K ﹤0.01% 1363
2014
Q4
Sell
-1,854
Closed -$180K 434
2014
Q3
$180K Buy
+1,854
New +$182K ﹤0.01% 411

Other funds holding ZBH

Capstone Investment Advisors's ZBH Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Zimmer Biomet (ZBH) stake by 46% in Q1 2026, selling an estimated $204K and leaving 2,591 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Capstone Investment Advisors first reported a position in ZBH in Q2 2014 and has held it in 24 quarters since. The position peaked at $5.05M in Q4 2021. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Capstone Investment Advisors held 2,591 shares of Zimmer Biomet worth $234K as of Q1 2026.
  • Capstone Investment Advisors sold 2,220 Zimmer Biomet shares in Q1 2026, an estimated $204K.
  • Zimmer Biomet made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1474 holding.
  • Capstone Investment Advisors first reported a position in Zimmer Biomet in Q2 2014 and has held it in 24 quarters since.
  • Capstone Investment Advisors's Zimmer Biomet position peaked at $5.05M in Q4 2021.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.